Canine mast cell tumors: Treatment options

Canine mast cell tumors are a heterogenous disease with a range of presentations and outcomes. As a result, a range of treatment modalities are used. This lecture will provide an in-depth exploration of various treatment modalities for canine mast cell tumors, with a focus on options that are readily accessible in primary care practice. Attendees will gain a comprehensive understanding of how these treatments work, their benefits, potential side effects, and factors that influence treatment decisions.

This session originally was presented at AVMA Convention 2024.

Learning Objectives:

• Gain a better understanding of the indications for surgical excision of mast cell tumors, the desired surgical margins, and possible complications
• Explore the use of Stelfonta and ideal patient selection
• Learn the clinical indications for Palladia, appropriate monitoring, and treatment of side effects

Dr. Kovac received her DVM from Texas A&M College of Veterinary Medicine in 2014 and subsequently completed a general rotating internship at VCA West Los Angeles in Los Angeles, California. This was followed by an oncology residency at The Ohio State University. She is a diplomate of the American College of Veterinary Internal Medicine - Oncology.